NCT07155551

Brief Summary

The objective of the study is to evaluate the short-term change in choroidal thickness induced by 3 prototype soft contact lenses for people with myopia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

August 25, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

August 15, 2025

Last Update Submit

August 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Choroidal Thickness from Baseline to After 1 Hour of Contact Lens Wear

    The change in sub-foveal choroidal thickness for the 3 study contact lenses will be compared from baseline to after 1 hour of contact lens wear. Measurements will be conducted on the right eye using a swept-source Optical Coherence Tomographer and measured in micrometers.

    After 1 hour of wearing each contact lens

Study Arms (3)

Lens A

EXPERIMENTAL
Device: Lens ADevice: Lens BDevice: Lens C

Lens B

EXPERIMENTAL
Device: Lens ADevice: Lens BDevice: Lens C

Lens C

EXPERIMENTAL
Device: Lens ADevice: Lens BDevice: Lens C

Interventions

Lens ADEVICE

Lens A of Study P/883/24/MO

Lens ALens BLens C
Lens BDEVICE

Lens B of Study P/883/24/MO

Lens ALens BLens C
Lens CDEVICE

Lens C of Study P/883/24/MO

Lens ALens BLens C

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Are 18-25 years of age (inclusive) and have full legal capacity to volunteer; Have read (or be read to) and signed the information and consent form; Habitually wear soft contact lenses or are spectacle wearers with previous experience of soft contact lens wear;
  • Are myopic with both eyes having a vertex corrected spherical equivalent non-cycloplegic refraction of at least -0.50 DS and no more than -4.50 DS;
  • Achieve at least LogMAR +0.10 with spherical equivalent refraction in each eye;
  • Are willing and able to maintain the appointment schedule and follow the measurement visit instructions which include no use of caffeine drinks, alcohol or other stimulants 12 hours before each measurement visit and no smoking or use of recreational cannabis 24 hours before the study visit;
  • Have not used a myopia control treatment within 2 years prior to Visit 0 (this includes multifocal spectacle or contact lens wear, orthokeratology, or atropine);
  • Typically sleeps at least 7 hours per night.

You may not qualify if:

  • Participating in any concurrent clinical or research study;
  • Have astigmatism of more than 1.00 DC in either eye as per non-cycloplegic refraction;
  • Have amblyopia in either eye or known to have any other binocular vision disorder, such as accommodative insufficiency;
  • Have any known active\* ocular disease and/or infection;
  • Have a systemic condition that in the opinion of the investigator may affect a study outcome variable. Examples include diabetes mellitus, hyperthyroidism, and active allergies;
  • Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable. Examples include antihistamine, atropine eye drops;
  • Have known sensitivity to the sodium fluorescein diagnostic pharmaceutical to be used in the study;
  • Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
  • Have undergone strabismus surgery, refractive error surgery or intraocular surgery;
  • Are an employee of the Centre for Ocular Research \& Education directly involved in this study (i.e. on the delegation log).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Ocular Research and Education at the School of Optometry and Vision Science at Waterloo University

Waterloo, Ontario, N2L 3G1, Canada

RECRUITING

MeSH Terms

Conditions

MyopiaRefractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: We understand that this falls outside the realm of a feasibility study given the intended sample size of 20 subjects. That being stated we selected Other in our resubmission, because in our opinion none of the "Primary Purpose" selection options fit the intent of studying the contact lenses impact on the choroid to detect the eyes' ability to respond to the defocus created by these lenses. These data will help inform further development decisions for an eventual clinical trial.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2025

First Posted

September 4, 2025

Study Start

August 25, 2025

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

September 4, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

The results are regarded as confidential to our business as Sponsor, and confidential for the selection of one device to use in a future efficacy trial. There are no plans for a public data repository for this study.

Locations